Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall digital discussions reflect a moderate interest in the study, with comments like personal experience about taking dutasteride and finasteride, and references to side effect risks. The tone balances curiosity and skepticism, with some users highlighting specific figures and corrections, which shows a engagement that suggests attentiveness but not deep analytical focus.
The discussions display mixed opinions, with some acknowledgment of the study's findings and others questioning the data or implications.
Participants show moderate curiosity, especially regarding side effects and real-world experiences, but lack in-depth exploration.
Several posts reference personal experiences or specific data points, indicating some level of thoughtful engagement, but overall discussion remains surface-level.
The discussions acknowledge the relevance of the topic with some noting potential impacts, but overall the influence on broader perspectives appears limited.
@cremieuxrecueil I think the side effect risk for both drugs is about the same. This video goes deep into it. I've been taking dutasteride for almost two years now and I feel the same as I did on finasteride. In fact I'm taking 3 pills a day now! https://t.co/BoHeykH9DO
え、これマジ…？ 「デュタステリドはフィナステリドより発毛率は高いが、副作用の発生率はほぼ同じ。」
RT @SHIBATAAA1: え、これマジ…？ 「デュタステリドはフィナステリドより発毛率は高いが、副作用の発生率はほぼ同じ。」
Correction: the GSK figure is 13.4%, not 20%. (The latter figure includes other adverse events which are not itemized in the table.) Source: Gubelin Harcha et al, 2014. https://t.co/FGxBVzu5Rd This figure is still 3.5x greater than Merck’s figure (3.8%).
This study assesses the safety, tolerability, and effectiveness of daily dutasteride (0.5 mg) in Japanese men with androgenetic alopecia over 52 weeks. Results indicate significant improvements in hair growth with…
A nationwide study in France found that finasteride is not linked to a higher overall risk of suicidal behaviors compared to dutasteride. However, in men with a history of mood disorders, finasteride was associated with…
This video explores whether low doses of dutasteride can effectively treat hair loss with fewer side effects, based on clinical studies and pharmacokinetic models.
This video discusses a clinical trial evaluating the safety and effectiveness of 0.2 mg low-dose Dutasteride in treating male androgenic alopecia, highlighting its potential as an undervalued treatment option.
Join the Channel Discord httpsdiscordgg8AeZs2qHE6 Want to contact me Follow this linktreekwxsoc Have hair loss questions Send me an email at kwkadvicepmme For video 1on1 Consultation Booking httpszcalcokwx Donate to the…
Join the channel Discord for discussions on hair loss theories and experiences. This video explores clinical literature on Dutasteride, including pharmacokinetics, effects on scalp DHT, and specific dosing strategies…
Join the Channel Discord httpsdiscordgg8AeZs2qHE6 Want to contact me Follow this linktreekwxsoc Have hair loss questions Send me an email at kwkadvicepmme For video 1on1 Consultation Booking httpszcalcokwx This video…
This video explores the efficacy and safety of different doses of dutasteride compared to placebo and finasteride in treating male pattern hair loss, emphasizing the importance of dual 5-reductase inhibition for…
Explore the efficacy and safety of Dutasteride compared to Finasteride in treating male pattern hair loss based on clinical trials and research studies.
This video discusses the phase 3 clinical trial of dutasteride, highlighting its effectiveness in promoting hair growth and reducing scalp DHT by 80% in male pattern baldness patients, emphasizing dual 5-reductase…
This video explores the efficacy and safety of various doses of dutasteride compared to placebo and finasteride for male androgenetic alopecia, based on clinical trial data. Learn about potential treatment options for…
This video explores the efficacy, safety, and tolerability of dutasteride and finasteride in treating male pattern hair loss, highlighting recent clinical studies and findings for effective management of androgenetic…
This video discusses the results of research on Dutasteride's effectiveness for male pattern hair loss, highlighting the importance of dual 5-reductase inhibition based on clinical studies and dose efficacy analysis.
Oral Finasteride is FDA-approved for androgenic alopecia. Dutasteride also treats the same symptoms, with some claiming it to be superior. This video examines scientific evidence supporting these claims and discusses…
@cremieuxrecueil I think the side effect risk for both drugs is about the same. This video goes deep into it. I've been taking dutasteride for almost two years now and I feel the same as I did on finasteride. In fact I'm taking 3 pills a day now! https://t.co/BoHeykH9DO
@sefauygunn https://t.co/Bn26o6m16r https://t.co/zlTnhhQywL https://t.co/HBnZVn16zX https://t.co/5TuxYgmrqo https://t.co/Pu49YtUDT5 https://t.co/NaUHFnuGxk https://t.co/YRoJs8TU9d https://t.co/abljYw8XqR
RT @SHIBATAAA1: え、これマジ…？ 「デュタステリドはフィナステリドより発毛率は高いが、副作用の発生率はほぼ同じ。」
え、これマジ…？ 「デュタステリドはフィナステリドより発毛率は高いが、副作用の発生率はほぼ同じ。」
Correction: the GSK figure is 13.4%, not 20%. (The latter figure includes other adverse events which are not itemized in the table.) Source: Gubelin Harcha et al, 2014. https://t.co/FGxBVzu5Rd This figure is still 3.5x greater than Merck’s figure (3.8%).